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Figure S1 
Synthesis of 2-((2-azidoethyl)disulfanyl)ethan-1-ol (5):
Triethylamine (5.4 mL, 38.8 mmol) was added to a solution of 2-Hydroxyethyl disulfide (5.0 g, 32.4 mmol) in tetrahydrofuran (20 mL)
firstly. The mixture was stirred at 0 °C under nitrogen protection for 10 min. Then a solution of methanesulfonyl chloride (2.5 mL, 32.3 mmol) in tetrahydrofuran (10 mL) was added dropwise to the above mixture, and the reaction mixture was closely monitored by TLC until the crude material was fully consumed. Then the reaction was quenched by water and extract by ethyl acetate (50 mL ×2).
The combined organic layers were dried over anhydrous sodium sulfate and evaporated. The intermediate was directly dissolved in DMF (15 mL), sodium azide was carefully added to the solution and the mixture was heated at 60 °C overnight. After fully reacted, the mixture was dilute in water (150 mL) and extract with ethyl acetate (50 mL ×3). The combined organic layers were dried over anhydrous sodium sulfate and evaporated. The crude product was further purified via chromatography 
Synthesis of 2-((2-azidoethyl)disulfanyl)ethyl carbonochloridate (6):
Triethylamine (320 μL, 2.23 mmol) was added to a solution of compound 5 (400 mg, 2.23 mmol) in anhydrous toluene (3 mL). The mixture was stirred at 0 °C for 10 min. Then a solution of triphosgene (220 mg, 0.74 mmol) in anhydrous toluene (2 mL) was added dropwise to the above mixture, and the S6 reaction mixture was closely monitored by TLC until the crude material was fully consumed (approximately 10 min). Then the mixture was directly purified via fast chromatography (silica gel) eluting with PE to PE: EA (10: 1) to get compound 6 as colorless oil (0.2 g, 37%) and directly used in the next step. 2-(6-(((2-((2-azidoethyl) 
Synthesis of (E)-2-(
Compound 4 70, 162.40, 153.60, 153.45, 146.02, 143.63, 141.99, 140.95, 134.76, 129.05, 127.98, 127.40, 127.11, 122.92, 116.97, 116.93, 111.83, 105.55, 77.31, 77.27 
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Synthesis of 1-ethyl-3,3-dimethyl-2-((E)-2-(6-(((2-((2-(4-(15-oxo-19-((3aS,4S,6aR)-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl)-2,5,8,11-tetraoxa-14-azanonadecyl)-1H-1,2,3-triazol-1-yl)ethyl)disulfanyl)ethoxy)carbonyl)amino)-2,3-dihydro-1H-xanthen-4-yl)vinyl)-3H-indol-1-ium iodide (P6):
Biotin-PEG4-Alkyne ( 162.80, 153.96, 153.53, 146.01, 143.89, 141.80, 140.90, 135.22, 130.30, 130.30, 129.11, 128.29, 127.39, 127.21, 125.57, 122.89, 117.11, 116.99, 114.56, 111.57, 105.11, 101.74, 77.23, 70.15, 70.13, 69.86, 69.39, 64.30, 62.66, 62.20, 60.72, 55.40, 50.65, 48.94, 40.32, 39.14, 37.50, 37.46, 35.30, 29.71, 29.10, 28.32, 28.32, 28.05, 27.84, 27.72, 27.43, 25.37, 20.30, 12.48. HRMS (ESI) Figure S1 . Working mechanism of P6. P6 was activated in the presence of intracellular GSH to release the fluorophore. Figure S6 . Calibration of cellular GSH levels and the corrected total cell fluorescence (CTCF). A) GSH concentration. B) CTCF
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